Clover Health Investments Stock Price, News & Analysis (NASDAQ:CLOV) $0.95 +0.01 (+1.06%) (As of 12/8/2023 ET) Add Compare Share Share Today's Range$0.93▼$0.9750-Day Range$0.88▼$1.1352-Week Range$0.71▼$1.63Volume5.48 million shsAverage Volume5.62 million shsMarket Capitalization$463.36 millionP/E RatioN/ADividend YieldN/APrice Target$1.92 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Clover Health Investments MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside101.7% Upside$1.92 Price TargetShort InterestBearish5.21% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.18Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.53) to ($0.32) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.63 out of 5 starsMedical Sector804th out of 942 stocksHospital & Medical Service Plans Industry10th out of 11 stocks 3.0 Analyst's Opinion Consensus RatingClover Health Investments has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, 1 hold rating, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.92, Clover Health Investments has a forecasted upside of 101.7% from its current price of $0.95.Amount of Analyst CoverageClover Health Investments has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted5.21% of the outstanding shares of Clover Health Investments have been sold short.Short Interest Ratio / Days to CoverClover Health Investments has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in Clover Health Investments has recently increased by 5.30%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldClover Health Investments does not currently pay a dividend.Dividend GrowthClover Health Investments does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLOV. Previous Next 1.8 News and Social Media Coverage News SentimentClover Health Investments has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Clover Health Investments this week, compared to 2 articles on an average week.Search InterestOnly 18 people have searched for CLOV on MarketBeat in the last 30 days. This is a decrease of -28% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Clover Health Investments to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Clover Health Investments insiders have not sold or bought any company stock.Percentage Held by Insiders21.82% of the stock of Clover Health Investments is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 19.95% of the stock of Clover Health Investments is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Clover Health Investments are expected to grow in the coming year, from ($0.53) to ($0.32) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clover Health Investments is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clover Health Investments is -1.98, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioClover Health Investments has a P/B Ratio of 1.30. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Clover Health Investments Stock (NASDAQ:CLOV)Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.Read More CLOV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLOV Stock News HeadlinesDecember 5, 2023 | finance.yahoo.comClover Health Investments, Corp.'s (NASDAQ:CLOV) top owners are individual investors with 57% stake, while 23% is held by insidersDecember 4, 2023 | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Clover Health Investments (CLOV) and Biomea Fusion (BMEA)December 9, 2023 | DTI Trader (Ad)New CBOE “special perk” helps traders target income every weekendYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. December 4, 2023 | americanbankingnews.comClover Health Investments, Corp. (NASDAQ:CLOV) Short Interest Up 5.3% in NovemberDecember 1, 2023 | bizjournals.comProfitability concerns lead Clover Health Investments to exit Centers for Medicare and Medicaid Services programNovember 30, 2023 | usatoday.comClover vs. Square: Differences, pros and cons in 2023November 26, 2023 | seekingalpha.comCLOV Clover Health Investments, Corp.November 10, 2023 | markets.businessinsider.comHold Rating on Clover Health Investments: Performance Upsides, Growth Concerns, and Capital Risk FactorsDecember 9, 2023 | Autonomix (Ad)[Investor Alert] Potential Breakthrough Medical Tech Investment OpportunityAutonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 8, 2023 | finance.yahoo.comHere's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn SituationNovember 7, 2023 | markets.businessinsider.comHold Rating on Clover Health: Mixed Financial Performance and Future UncertaintyNovember 7, 2023 | finance.yahoo.comQ3 2023 Clover Health Investments Corp Earnings CallNovember 7, 2023 | msn.comClover Health Investments, Augmedix among healthcare moversNovember 7, 2023 | markets.businessinsider.comWhat's Going On With Clover Health Stock Tuesday?November 7, 2023 | finance.yahoo.comClover Health and WellBe Senior Medical Partner to Bring In-home Medical Care to Atlanta Patients and Across Rural GeorgiaNovember 7, 2023 | seekingalpha.comClover Health Investments: Improving Fundamentals Inspires Bullish OutlookNovember 7, 2023 | msn.comVegetarian restaurant chain Clover Food Lab files for bankruptcyNovember 6, 2023 | finance.yahoo.comClover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 GuidanceNovember 6, 2023 | finance.yahoo.comClover Health Investments Corp (CLOV) Reports Q3 2023 Earnings: Improved Financial Performance ...November 6, 2023 | seekingalpha.comClover Health Investments, Corp. 2023 Q3 - Results - Earnings Call PresentationNovember 1, 2023 | finance.yahoo.comClover Health Promotes Karen Soares to General CounselOctober 17, 2023 | finance.yahoo.comClover Health to Report Third Quarter 2023 Financial Results on November 6, 2023October 12, 2023 | finance.yahoo.comClinician Use of Clover Assistant is Associated with Earlier Identification and Management of DiabetesSeptember 22, 2023 | finance.yahoo.comClover Health to Present at Maxim Group Emerging Growth in A.I. Virtual Conference on September 26, 2023September 20, 2023 | finance.yahoo.comClover Health to Host Virtual Clover Assistant Showcase on October 12, 2023September 14, 2023 | msn.comWalgreens unveils new healthcare strategy for long-term growthAugust 29, 2023 | markets.businessinsider.comWhat's Going On With Clover Health Investments Stock?See More Headlines Receive CLOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clover Health Investments and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/06/2023Today12/09/2023Fiscal Year End12/31/2023Next Earnings (Estimated)2/27/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Hospital & medical service plans Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CLOV CUSIPN/A CIK1801170 Webwww.cloverhealth.com Phone201-432-2133FaxN/AEmployees656Year FoundedN/APrice Target and Rating Average Stock Price Target$1.92 High Stock Price Target$3.00 Low Stock Price Target$1.25 Potential Upside/Downside+101.7%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($0.48) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-338,840,000.00 Net Margins-9.37% Pretax Margin-9.35% Return on Equity-75.65% Return on Assets-21.86% Debt Debt-to-Equity RatioN/A Current Ratio1.27 Quick Ratio1.27 Sales & Book Value Annual Sales$3.48 billion Price / Sales0.13 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book1.30Miscellaneous Outstanding Shares487,640,000Free Float381,240,000Market Cap$463.36 million OptionableNot Optionable Beta1.91 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Vivek Garipalli (Age 44)Co-Founder & Executive Chairman Mr. Andrew Toy (Age 44)Co-Founder, CEO & Director Comp: $1.01MMr. Scott J. Leffler (Age 48)Chief Financial Officer Comp: $420.19kMr. Brady Priest J.D. (Age 46)Chief Executive Officer of Home Care Comp: $587.36kMr. Conrad Wai (Age 42)Chief Technology Officer Mr. Derrick L. NuemanHead of Investor Relations & Corporate strategyMs. Wendy RicheyChief Compliance OfficerMs. Karen SoaresGeneral Counsel, Senior VP & Corporate SecretaryMs. Rachel FishChief People OfficerMs. Jamie L. Reynoso (Age 53)Chief Executive Officer of Medicare Advantage Comp: $461.74kMore ExecutivesKey CompetitorsDragoneer Growth OpportunitiesNYSE:DGNRSkillzNYSE:SKLZAlignment HealthcareNASDAQ:ALHCAlectorNASDAQ:ALECAerovate TherapeuticsNASDAQ:AVTEView All CompetitorsInsiders & InstitutionsCitigroup Inc.Bought 363,427 shares on 12/6/2023Ownership: 0.076%Wolverine Trading LLCBought 34,900 shares on 11/16/2023Ownership: 0.000%GTS Securities LLCBought 35,000 shares on 11/16/2023Ownership: 0.000%AQR Capital Management LLCBought 333,868 shares on 11/15/2023Ownership: 0.163%Legal & General Group PlcBought 89,373 shares on 11/15/2023Ownership: 0.056%View All Insider TransactionsView All Institutional Transactions CLOV Stock Analysis - Frequently Asked Questions Should I buy or sell Clover Health Investments stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clover Health Investments in the last year. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" CLOV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLOV, but not buy additional shares or sell existing shares. View CLOV analyst ratings or view top-rated stocks. What is Clover Health Investments' stock price target for 2024? 3 brokers have issued 12-month target prices for Clover Health Investments' stock. Their CLOV share price targets range from $1.25 to $3.00. On average, they predict the company's stock price to reach $1.92 in the next twelve months. This suggests a possible upside of 101.7% from the stock's current price. View analysts price targets for CLOV or view top-rated stocks among Wall Street analysts. How have CLOV shares performed in 2023? Clover Health Investments' stock was trading at $0.9295 at the beginning of the year. Since then, CLOV shares have increased by 2.2% and is now trading at $0.9502. View the best growth stocks for 2023 here. Are investors shorting Clover Health Investments? Clover Health Investments saw a increase in short interest in November. As of November 15th, there was short interest totaling 25,430,000 shares, an increase of 5.3% from the October 31st total of 24,150,000 shares. Based on an average daily volume of 4,110,000 shares, the short-interest ratio is currently 6.2 days. View Clover Health Investments' Short Interest. When is Clover Health Investments' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024. View our CLOV earnings forecast. How were Clover Health Investments' earnings last quarter? Clover Health Investments, Corp. (NASDAQ:CLOV) issued its earnings results on Monday, November, 6th. The company reported ($0.09) earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.01. The company earned $482.07 million during the quarter, compared to analysts' expectations of $491.30 million. Clover Health Investments had a negative trailing twelve-month return on equity of 75.65% and a negative net margin of 9.37%. Who are Clover Health Investments' major shareholders? Clover Health Investments' stock is owned by many different institutional and retail investors. Top institutional investors include PNC Financial Services Group Inc. (1.05%), Charles Schwab Investment Management Inc. (0.38%), Qube Research & Technologies Ltd (0.28%), Connor Clark & Lunn Investment Management Ltd. (0.17%), Northern Trust Corp (0.16%) and AQR Capital Management LLC (0.16%). Insiders that own company stock include Anna U Loengard, Chamath Palihapitiya, Chelsea Clinton and Lee Shapiro. View institutional ownership trends. How do I buy shares of Clover Health Investments? Shares of CLOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:CLOV) was last updated on 12/9/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clover Health Investments, Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.